(Q39814985)

14 September 2017

1 reference

title

Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication (English)

1 reference

14 September 2017

1 reference

1 reference

1 reference

Dettelbach HR

1

1 reference

14 September 2017

Aviado DM

series ordinal

2

1 reference

14 September 2017

language of work or name

1 reference

1 January 1985

1 reference

The Journal of Clinical Pharmacology

14 September 2017

published in

1 reference

14 September 2017

volume

25

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

8-26

1 reference

THEOBROMINE SODIUM SALICYLATE AS A VASODILATOR

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1985.TB02796.X

Impaired red cell deformability in peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1985.TB02796.X

The importance of erythrocyte deformability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1985.TB02796.X

Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1985.TB02796.X

The Effect of Pentoxifylline on Erythrocyte Deformability and on Phosphatide Fatty Acid Distribution in the Erythrocyte Membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1985.TB02796.X

Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1985.TB02796.X

Metabolic pathway of theobromine in the rat and identification of two new metabolites in human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1985.TB02796.X

The influence of 1-(5-oxohexyl-)3.7-dimethylxanthine (BL 191) on the endocrine and exocrine pancreatic function in man during and following secretin and cholecystokinin-pancreozymin stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1985.TB02796.X

The influence of pentoxyfylline [1-(5-oxohexyl-) 3,7-dimethylxanthine] (BL 191) on the insulin secretion induced by glibenclamide and by arginine/glucose in the perfused pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1985.TB02796.X

Analysis of pregnanediol in urine: trental interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1985.TB02796.X

Effects of continuous administration of dietary theobromine on rat testicular weight and morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1985.TB02796.X

10.1002/J.1552-4604.1985.TB02796.X

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference